Robert C. Stassen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Robert C. Stassen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jan A. Ten Bosch
Department of Traumatology, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands
1 shared publication - Kostan W. Reisinger
Trauma Unit, Department of Surgery, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands
1 shared publication - Martijn Poeze
Department of Traumatology, Maastricht University Medical Centre+, 6229HX Maastricht, The Netherlands
1 shared publication - Moaath Al-Ali
Department of Traumatology, Maastricht University Medical Centre+, 6229HX Maastricht, The Netherlands
1 shared publication - Taco Johan Blokhuis
Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 29 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2046
High Prevalence of Sarcopenia in Older Trauma Patients: A Pilot Study
Sarcopenia is related to adverse outcomes in various populations. However, little is known about the prevalence of sarcopenia in polytrauma patients. Identifying the number of patients at risk of adverse outcome will increase awareness to prevent further loss of muscle mass. We utilized data from a regional prospective trauma registry of all polytrauma patients presented between 2015 and 2019 at a single level-I trauma center. Subjects were screened for availability of computed tomography (CT)-abdomen and height in order to calculate skeletal mass index, which was used to estimate sarcopenia. Additional parameters regarding clinical outcome were assessed. Univariate analysis was performed to identify parameters related adverse outcome and, if identified, entered in a multivariate regression analysis. Prevalence of sarcopenia was 33.5% in the total population but was even higher in older age groups (range 60–79 years), reaching 82 % in patients over 80 years old. Sarcopenia was related to 30-day or in-hospital mortality (p = 0.032), as well as age (p < 0.0001), injury severity score (p = 0.026), and Charlson comorbidity index (p = 0.001). Log rank analysis identified sarcopenia as an independent predictor of 30-day mortality (p = 0.032). In conclusion, we observed a high prevalence of sarcopenia among polytrauma patients, further increasing in older patients. In addition, sarcopenia was identified as a predictor for 30-day mortality, underlining the clinical significance of identification of low muscle mass on a CT scan that is already routinely obtained in most trauma patients.
- 29 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2046
Open AccessHigh Prevalence of Sarcopenia in Older Trauma Patients: A Pilot Study
Sarcopenia is related to adverse outcomes in various populations. However, little is known about the prevalence of sarcopenia in polytrauma patients. Identifying the number of patients at risk of adverse outcome will increase awareness to prevent further loss of muscle mass. We utilized data from a regional prospective trauma registry of all polytrauma patients presented between 2015 and 2019 at a single level-I trauma center. Subjects were screened for availability of computed tomography (CT)-abdomen and height in order to calculate skeletal mass index, which was used to estimate sarcopenia. Additional parameters regarding clinical outcome were assessed. Univariate analysis was performed to identify parameters related adverse outcome and, if identified, entered in a multivariate regression analysis. Prevalence of sarcopenia was 33.5% in the total population but was even higher in older age groups (range 60–79 years), reaching 82 % in patients over 80 years old. Sarcopenia was related to 30-day or in-hospital mortality (p = 0.032), as well as age (p < 0.0001), injury severity score (p = 0.026), and Charlson comorbidity index (p = 0.001). Log rank analysis identified sarcopenia as an independent predictor of 30-day mortality (p = 0.032). In conclusion, we observed a high prevalence of sarcopenia among polytrauma patients, further increasing in older patients. In addition, sarcopenia was identified as a predictor for 30-day mortality, underlining the clinical significance of identification of low muscle mass on a CT scan that is already routinely obtained in most trauma patients.